Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Norenstedt

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Surgery|May 20, 2017
Primary hyperparathyroidism, hypercalciuria, and bone recovery after parathyroidectomyInga-Lena Nilsson, Sophie Norenstedt, Jan Zedenius, et al.
Surgery|October 6, 2015
FGF23, metabolic risk factors, and blood pressure in patients with primary hyperparathyroidism undergoing parathyroid adenomectomyInga-Lena Nilsson, Sophie Norenstedt, Fredrik Granath, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 12, 2013
Vitamin D supplementation after parathyroidectomy: effect on bone mineral density-a randomized double-blind studySophie Norenstedt, Ylva Pernow, Jan Zedenius, et al.
European Journal of Endocrinology|November 22, 2014
Health-related quality of life after successful surgery for primary hyperparathyroidism: no additive effect from vitamin D supplementation: results of a double-blind randomized studyViveca Åberg, Sophie Norenstedt, Jan Zedenius, et al.
European Journal of Endocrinology|September 13, 2013
Primary hyperparathyroidism and metabolic risk factors, impact of parathyroidectomy and vitamin D supplementation, and results of a randomized double-blind studySophie Norenstedt, Ylva Pernow, Kerstin Brismar, et al.
Clinical Epidemiology|April 14, 2011
Breast cancer associated with primary hyperparathyroidism: a nested case control studySophie Norenstedt, Fredrik Granath, Anders Ekbom, et al.
Endocrine Connections|February 5, 2015
Tumour nuclear oestrogen receptor beta 1 correlates inversely with parathyroid tumour weightFelix Haglund, Gustaf Rosin, Inga-Lena Nilsson, et al.
The British Journal of Surgery|June 6, 2025
Omitting completion axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases undergoing mastectomy: results from the prospective SENOMIC trialYvette Andersson, Leif Bergkvist, Lisa Rydén, et al.
Cell Reports|August 1, 2019
Monocytes Acquire the Ability to Prime Tissue-Resident T Cells via IL-10-Mediated TGF-β ReleaseElizabeth A Thompson, Patricia A Darrah, Kathryn E Foulds, et al.
The New England Journal of Medicine|April 10, 2024
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node MetastasesJana de Boniface, Tove Filtenborg Tvedskov, Lisa Rydén, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Surgery|May 20, 2017
Primary hyperparathyroidism, hypercalciuria, and bone recovery after parathyroidectomyInga-Lena Nilsson, Sophie Norenstedt, Jan Zedenius, et al.
Surgery|October 6, 2015
FGF23, metabolic risk factors, and blood pressure in patients with primary hyperparathyroidism undergoing parathyroid adenomectomyInga-Lena Nilsson, Sophie Norenstedt, Fredrik Granath, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 12, 2013
Vitamin D supplementation after parathyroidectomy: effect on bone mineral density-a randomized double-blind studySophie Norenstedt, Ylva Pernow, Jan Zedenius, et al.
European Journal of Endocrinology|November 22, 2014
Health-related quality of life after successful surgery for primary hyperparathyroidism: no additive effect from vitamin D supplementation: results of a double-blind randomized studyViveca Åberg, Sophie Norenstedt, Jan Zedenius, et al.
European Journal of Endocrinology|September 13, 2013
Primary hyperparathyroidism and metabolic risk factors, impact of parathyroidectomy and vitamin D supplementation, and results of a randomized double-blind studySophie Norenstedt, Ylva Pernow, Kerstin Brismar, et al.
Clinical Epidemiology|April 14, 2011
Breast cancer associated with primary hyperparathyroidism: a nested case control studySophie Norenstedt, Fredrik Granath, Anders Ekbom, et al.
Endocrine Connections|February 5, 2015
Tumour nuclear oestrogen receptor beta 1 correlates inversely with parathyroid tumour weightFelix Haglund, Gustaf Rosin, Inga-Lena Nilsson, et al.
The British Journal of Surgery|June 6, 2025
Omitting completion axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases undergoing mastectomy: results from the prospective SENOMIC trialYvette Andersson, Leif Bergkvist, Lisa Rydén, et al.
Cell Reports|August 1, 2019
Monocytes Acquire the Ability to Prime Tissue-Resident T Cells via IL-10-Mediated TGF-β ReleaseElizabeth A Thompson, Patricia A Darrah, Kathryn E Foulds, et al.
The New England Journal of Medicine|April 10, 2024
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node MetastasesJana de Boniface, Tove Filtenborg Tvedskov, Lisa Rydén, et al.
Pageof 1